Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ADOC:FP

69.0200 EUR 4.1000 6.32%

As of 11:36:27 ET on 01/30/2015.

Snapshot for Adocia (ADOC)

Open: 64.9800 Day's Range: 63.2600 - 70.4900 Volume: 188,983
Previous Close: 64.9200 52wk Range: 6.9400 - 70.4900 1-Yr Rtn: +787.15%

Stock Chart for ADOC

No chart data available.
  • ADOC:FP 69.0200
  • 1D
  • 1M
  • 1Y
64.9200
Interactive ADOC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADOC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -1.1400
Est. PEG Ratio -
Market Cap (M EUR) 429.03
Shares Outstanding (M) 6.22
30 Day Average Volume 233,817
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADOC

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ADOC

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.

Gerard SoulaChairman/CEOValerie DanaguezianChief Financial Officer
Olivier SoulaDir:R&D/Deputy Gen MgrRemi SoulaDir:Business Development
More Company Profile & Key Executives for ADOC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil